195 related articles for article (PubMed ID: 11980587)
1. Binding of protegrin-1 to Pseudomonas aeruginosa and Burkholderia cepacia.
Albrecht MT; Wang W; Shamova O; Lehrer RI; Schiller NL
Respir Res; 2002; 3(1):18. PubMed ID: 11980587
[TBL] [Abstract][Full Text] [Related]
2. Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa.
Hendry J; Butler S; Elborn JS; Govan JR; Nelson J; Shale DJ; Webb AK
J Infect; 2000 Mar; 40(2):164-70. PubMed ID: 10841094
[TBL] [Abstract][Full Text] [Related]
3. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward.
Döring G; Jansen S; Noll H; Grupp H; Frank F; Botzenhart K; Magdorf K; Wahn U
Pediatr Pulmonol; 1996 Feb; 21(2):90-100. PubMed ID: 8882212
[TBL] [Abstract][Full Text] [Related]
4. Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolates.
Livermore DM; Mushtaq S; Ge Y; Warner M
Int J Antimicrob Agents; 2009 Nov; 34(5):402-6. PubMed ID: 19428220
[TBL] [Abstract][Full Text] [Related]
5. Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis.
Simpson IN; Finlay J; Winstanley DJ; Dewhurst N; Nelson JW; Butler SL; Govan JR
J Antimicrob Chemother; 1994 Sep; 34(3):353-61. PubMed ID: 7530242
[TBL] [Abstract][Full Text] [Related]
6. Interspecies communication between Burkholderia cepacia and Pseudomonas aeruginosa.
Lewenza S; Visser MB; Sokol PA
Can J Microbiol; 2002 Aug; 48(8):707-16. PubMed ID: 12381027
[TBL] [Abstract][Full Text] [Related]
7. Identification of Pseudomonas aeruginosa, Burkholderia cepacia complex, and Stenotrophomonas maltophilia in respiratory samples from cystic fibrosis patients using multiplex PCR.
da Silva Filho LV; Tateno AF; Velloso Lde F; Levi JE; Fernandes S; Bento CN; Rodrigues JC; Ramos SR
Pediatr Pulmonol; 2004 Jun; 37(6):537-47. PubMed ID: 15114555
[TBL] [Abstract][Full Text] [Related]
8. Interspecies biofilms of Pseudomonas aeruginosa and Burkholderia cepacia.
Tomlin KL; Coll OP; Ceri H
Can J Microbiol; 2001 Oct; 47(10):949-54. PubMed ID: 11718549
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of the Burkholderia cepacia complex and Pseudomonas aeruginosa to transducing bacteriophages.
Nzula S; Vandamme P; Govan JR
FEMS Immunol Med Microbiol; 2000 Aug; 28(4):307-12. PubMed ID: 10891654
[TBL] [Abstract][Full Text] [Related]
10. Serum IgG response to Burkholderia cepacia outer membrane antigens in cystic fibrosis: assessment of cross-reactivity with Pseudomonas aeruginosa.
Lacy DE; Smith AW; Stableforth DE; Smith G; Weller PH; Brown MR
FEMS Immunol Med Microbiol; 1995 Feb; 10(3-4):253-61. PubMed ID: 7539670
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients.
Traczewski MM; Brown SD
Antimicrob Agents Chemother; 2006 Feb; 50(2):819-21. PubMed ID: 16436756
[TBL] [Abstract][Full Text] [Related]
12. A novel mucin-sulphatase activity found in Burkholderia cepacia and Pseudomonas aeruginosa.
Jansen HJ; Hart CA; Rhodes JM; Saunders JR; Smalley JW
J Med Microbiol; 1999 Jun; 48(6):551-557. PubMed ID: 10359304
[TBL] [Abstract][Full Text] [Related]
13. The effect of human lactoferrin on the MICs of doxycycline and rifampicin for Burkholderia cepacia and Pseudomonas aeruginosa strains.
Alkawash M; Head M; Alshami I; Soothill JS
J Antimicrob Chemother; 1999 Sep; 44(3):385-7. PubMed ID: 10511407
[TBL] [Abstract][Full Text] [Related]
14. Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis.
Karpati F; Jonasson J
Mol Cell Probes; 1996 Dec; 10(6):397-403. PubMed ID: 9025076
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex.
Nicholson A; Perry JD; James AL; Stanforth SP; Carnell S; Wilkinson K; Anjam Khan CM; De Soyza A; Gould FK
Int J Antimicrob Agents; 2012 Jan; 39(1):27-32. PubMed ID: 21993484
[TBL] [Abstract][Full Text] [Related]
16. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils.
Turner J; Cho Y; Dinh NN; Waring AJ; Lehrer RI
Antimicrob Agents Chemother; 1998 Sep; 42(9):2206-14. PubMed ID: 9736536
[TBL] [Abstract][Full Text] [Related]
17. Association of resistance to trimethoprim/sulphamethoxazole, chloramphenicol and quinolones with changes in major outer membrane proteins and lipopolysaccharide in Burkholderia cepacia.
Rajyaguru JM; Muszynski MJ
J Antimicrob Chemother; 1997 Dec; 40(6):803-9. PubMed ID: 9462431
[TBL] [Abstract][Full Text] [Related]
18. Antigenic analysis of Pseudomonas aeruginosa and Pseudomonas cepacia GroEL proteins and demonstration of a lipopolysaccharide-associated GroEL fraction in P. aeruginosa.
Jensen P; Fomsgaard A; Shand G; Hindersson P; Høiby N
APMIS; 1993 Aug; 101(8):621-30. PubMed ID: 7692893
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolone susceptibilities of efflux-mediated multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia.
Zhang L; Li XZ; Poole K
J Antimicrob Chemother; 2001 Oct; 48(4):549-52. PubMed ID: 11581236
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary function, serum markers of inflammation, and IgG antibodies to core lipopolysaccharide of Burkholderia cepacia in adults with cystic fibrosis, following colonization with Burkholderia cepacia.
Hendry J; Nixon L; Dodd M; Elborn JS; Govan J; Shale DJ; Webb AK
Pediatr Pulmonol; 2000 Jan; 29(1):8-10. PubMed ID: 10613780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
